Recently, Guangzhou HC Pharmaceutical once again received good news that our company has undertaken the consistency evaluation project for the client's dopamine hydrochloride injection, which has been officially approved by the National Medical Products Administration.

On behalf of the client, our company undertook all pharmaceutical research and registration applications for the "Dopamine Hydrochloride Injection" project. With the trust and close cooperation of the client, the Guangzhou HC Pharmaceutical team fully utilized their experience in formulation development, successfully completed various development tasks, and was successfully approved.

In recent years, our company has repeatedly assisted large state-owned enterprises and listed companies in China to pass consistency evaluations, including the first project in the country to pass CDE evaluation and the successful bidding and procurement project. In terms of customer feedback, we have received consistent praise. After years of accumulation and customer trust, our company has gradually matured and improved in technology and services, The continuous challenges and breakthroughs in research and development also ensure that our team is at the forefront of the industry.

Guangzhou HC Pharmaceutical will continue to maintain a spirit of research and dedication to the future through technology, assisting more enterprises in high-quality, efficient, and high-speed development.